亲爱的研友该休息了!由于当前在线用户较少,发布求助请尽量完整的填写文献信息,科研通机器人24小时在线,伴您度过漫漫科研夜!身体可是革命的本钱,早点休息,好梦!

miR-22 promotes immunosuppression via activating JAK/STAT3 signaling in cutaneous squamous cell carcinoma

肿瘤微环境 癌症研究 CCL22型 趋化因子 免疫疗法 免疫抑制 SOCS3 免疫学 生物 肿瘤进展 癌症 信号转导 免疫系统 车站3 CXCL10型 细胞生物学 遗传学
作者
Shukai Yuan,Tong Zhu,Jianan Wang,Ruoyu Jiang,Aofeng Shu,Zhenlei Zhang,Peitao Zhang,Xuequan Feng,Li Zhao
出处
期刊:Carcinogenesis [Oxford University Press]
卷期号:44 (7): 549-561 被引量:1
标识
DOI:10.1093/carcin/bgad055
摘要

Abstract Immunotherapy is the only approved systemic therapy for advanced cutaneous squamous cell carcinoma (cSCC), however, roughly 50% of patients do not respond to the therapy and resistance often occurs over time to those who initially respond. Immunosuppression could have a critical role in developing treatment resistance, thus, understanding the mechanisms of how immunosuppression is developed and regulated may be the key to improving clinical diagnosis and treatment strategies for cSCC. Here, through using a series of immunocompetent genetically engineered mouse models, we demonstrate that miR-22 promotes cSCC development by establishing regulatory T cells (Tregs)-mediated immunosuppressive tumor microenvironment (TME) in a tumor cell autonomous manner. Mechanism investigation revealed that miR-22 elicits the constitutive activation of JAK/STAT3 signaling by directly targeting its suppressor SOCS3, which augments cancer cell-derived chemokine secretion and Tregs recruitment. Epithelial-specific and global knockouts of miR-22 repress papilloma and cSCC development and progression, manifested with reduced Tregs infiltration and elevated CD8+ T cell activation. Transcriptomic analysis and functional rescue study confirmed CCL17, CCL20 and CCL22 as the main affected chemokines that mediate the chemotaxis between miR-22 highly expressing keratinocyte tumor cells and Tregs. Conversely, overexpression of SOCS3 reversed miR-22-induced Tregs recruitment toward tumor cells. Clinically, gradually increasing Tregs infiltration during cSCC progression was negatively correlated with SOCS3 abundance, supported by previously documented elevated miR-22 levels. Thus, our study uncovers a novel miR-22–SOCS3–JAK/STAT3–chemokines regulatory mechanism in defining the immunosuppressive TME and highlights the promising clinical application value of miR-22 as a common targeting molecule against JAK/STAT3 signaling and immune escape in cSCC.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
大幅提高文件上传限制,最高150M (2024-4-1)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
魏白晴完成签到,获得积分10
1秒前
周青春偶像完成签到 ,获得积分10
11秒前
饱满语风完成签到 ,获得积分10
1分钟前
科研通AI2S应助啊呜采纳,获得10
1分钟前
善学以致用应助zhangxr采纳,获得10
2分钟前
leslie完成签到 ,获得积分10
2分钟前
科研通AI2S应助showrain采纳,获得10
2分钟前
2分钟前
姚芭蕉完成签到 ,获得积分0
2分钟前
3分钟前
Jason发布了新的文献求助10
3分钟前
小强完成签到 ,获得积分10
3分钟前
华仔应助Jason采纳,获得10
3分钟前
3分钟前
mengyuhuan完成签到 ,获得积分0
3分钟前
fleeper发布了新的文献求助10
3分钟前
DrCuiTianjin完成签到 ,获得积分10
3分钟前
4分钟前
5分钟前
lik发布了新的文献求助10
5分钟前
5分钟前
科研通AI2S应助lik采纳,获得10
5分钟前
小巫发布了新的文献求助10
5分钟前
dolphin完成签到 ,获得积分0
5分钟前
6分钟前
科研通AI2S应助科研通管家采纳,获得10
6分钟前
小巫发布了新的文献求助10
6分钟前
Jasper应助cheesy采纳,获得10
6分钟前
去去去去发布了新的文献求助10
6分钟前
7分钟前
cheesy发布了新的文献求助10
7分钟前
7分钟前
FMHChan完成签到,获得积分10
7分钟前
风信子deon01完成签到,获得积分10
7分钟前
7分钟前
于洋完成签到 ,获得积分10
8分钟前
ZhJF完成签到 ,获得积分10
8分钟前
充电宝应助科研通管家采纳,获得10
8分钟前
半岛岛发布了新的文献求助10
8分钟前
科研通AI2S应助athena采纳,获得10
9分钟前
高分求助中
The Oxford Handbook of Social Cognition (Second Edition, 2024) 1050
Kinetics of the Esterification Between 2-[(4-hydroxybutoxy)carbonyl] Benzoic Acid with 1,4-Butanediol: Tetrabutyl Orthotitanate as Catalyst 1000
The Young builders of New china : the visit of the delegation of the WFDY to the Chinese People's Republic 1000
Rechtsphilosophie 1000
юрские динозавры восточного забайкалья 800
Handbook of Qualitative Cross-Cultural Research Methods 600
Chen Hansheng: China’s Last Romantic Revolutionary 500
热门求助领域 (近24小时)
化学 医学 生物 材料科学 工程类 有机化学 生物化学 物理 内科学 纳米技术 计算机科学 化学工程 复合材料 基因 遗传学 催化作用 物理化学 免疫学 量子力学 细胞生物学
热门帖子
关注 科研通微信公众号,转发送积分 3139573
求助须知:如何正确求助?哪些是违规求助? 2790458
关于积分的说明 7795318
捐赠科研通 2446925
什么是DOI,文献DOI怎么找? 1301511
科研通“疑难数据库(出版商)”最低求助积分说明 626248
版权声明 601159